Abstract:With the growing problem of the emergence of antibiotic-resistant bacteria, the search for alternative ways to combat bacterial infections is extremely urgent. While analyzing the effect of antimicrobial peptides (AMPs) on immunocompetent cells, their effect on all parts of the immune system, and on humoral and cellular immunity, is revealed. AMPs have direct effects on neutrophils, monocytes, dendritic cells, T-lymphocytes, and mast cells, participating in innate immunity. They act on B-lymphocytes indirectly, enhancing the induction of antigen-specific immunity, which ultimately leads to the activation of adaptive immunity. The adjuvant activity of AMPs in relation to bacterial and viral antigens was the reason for their inclusion in vaccines and made it possible to formulate the concept of a “defensin vaccine” as an innovative basis for constructing vaccines. The immunomodulatory function of AMPs involves their influence on cells in the nearest microenvironment, recruitment and activation of other cells, supporting the response to pathogenic microorganisms and completing the inflammatory process, thus exhibiting a systemic effect. For the successful use of AMPs in medical practice, it is necessary to study their immunomodulatory activity in detail, taking into account their pleiotropy. The degree of maturity of the immune system and microenvironment can contribute to the prevention of complications and increase the effectiveness of therapy, since AMPs can suppress inflammation in some circumstances, but aggravate the response and damage of organism in others. It should also be taken into account that the real functions of one or another AMP depend on the types of total regulatory effects on the target cell, and not only on properties of an individual peptide. A wide spectrum of biological activity, including direct effects on pathogens, inactivation of bacterial toxins and influence on immunocompetent cells, has attracted the attention of researchers, however, the cytostatic activity of AMPs against normal cells, as well as their allergenic properties and low stability to host proteases, are serious limitations for the medical use of AMPs. In this connection, the tasks of searching for compounds that selectively affect the target and development of an appropriate method of application become critically important. The scope of this review is to summarize the current concepts and newest advances in research of the immunomodulatory activity of natural and synthetic AMPs, and to examine the prospects and limitations of their medical use.

Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues

Bomidin: an Optimized Antimicrobial Peptide with Broad Antiviral Activity Against Enveloped Viruses.

Little Antimicrobial Peptides with Big Therapeutic Roles

Immunomodulatory and Allergenic Properties of Antimicrobial Peptides

Overview on the Recent Study of Antimicrobial Peptides: Origins, Functions, Relative Mechanisms and Application

Progress of Antimicrobial Peptides Research and Its Current Therapeutic Application

The Contribution of Antimicrobial Peptides to Immune Cell Function: A Review of Recent Advances

Chemically modified and conjugated antimicrobial peptides against superbugs.

Antimicrobial peptides: Promising alternatives in the postfeeding antibiotic era: WANG et al.

Antimicrobial Peptides against Bacterial Pathogens: Innovative Delivery Nanosystems for Pharmaceutical Applications

Antimicrobial Peptides towards Clinical Application—A Long History to Be Concluded

A novel bioinformatic method for the identification of antimicrobial peptides in metagenomes

Enhanced Cell Selectivity of Hybrid Peptides with Potential Antimicrobial Activity and Immunomodulatory Effect.

Biochemistry, Mechanistic Intricacies, and Therapeutic Potential of Antimicrobial Peptides: An Alternative to Traditional Antibiotics

The Antimicrobial Peptides and Their Potential Clinical Applications.

Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era

The role of natural antimicrobial peptides during infection and chronic inflammation

Antimicrobial peptides designed by computational analysis of proteomes

Functional and toxicological evaluation of the MAA-41: a novel rationally designed antimicrobial peptide using hybridization and modification methods from LL-37 and BMAP-28.

Advances in the Delivery and Application of Antimicrobial Peptide-Based Nanomaterials

Associating Biological Activity and Predicted Structure of Antimicrobial Peptides from Amphibians and Insects